Literature DB >> 1955395

Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.

O Johdo1, Y Watanabe, T Ishikura, A Yoshimoto, H Naganawa, T Sawa, T Takeuchi.   

Abstract

New anthracycline antibiotics, identified as epsilon-rhodomycinone glycosides, were isolated from the culture broth of a blocked mutant of beta-rhodomycin-producing Streptomyces violaceus A262. They were designated as epelmycins A, B, C, D and E, and assayed for their in vitro cytotoxicities against murine leukemic L1210 cell culture and the antimicrobial activities in comparison with known anthracycline antibiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955395     DOI: 10.7164/antibiotics.44.1121

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Insights in the glycosylation steps during biosynthesis of the antitumor anthracycline cosmomycin: characterization of two glycosyltransferase genes.

Authors:  Leandro M Garrido; Felipe Lombó; Irfan Baig; Mohammad Nur-E-Alam; Renata L A Furlan; Charlotte C Borda; Alfredo Braña; Carmen Méndez; José A Salas; Jürgen Rohr; Gabriel Padilla
Journal:  Appl Microbiol Biotechnol       Date:  2006-06-30       Impact factor: 4.813

2.  Rare actinobacteria: a potential source of bioactive polyketides and peptides.

Authors:  Sunita Bundale; Jaya Singh; Deovrat Begde; Nandita Nashikkar; Avinash Upadhyay
Journal:  World J Microbiol Biotechnol       Date:  2019-06-11       Impact factor: 3.312

3.  Novel aromatic polyketides from soil Streptomyces spp.: purification, characterization and bioactivity studies.

Authors:  Sunita Bundale; Deovrat Begde; Dhanashree Pillai; Karishma Gangwani; Nandita Nashikkar; Tukaram Kadam; Avinash Upadhyay
Journal:  World J Microbiol Biotechnol       Date:  2018-04-24       Impact factor: 3.312

4.  Rhodomycin analogues from Streptomyces purpurascens: isolation, characterization and biological activities.

Authors:  Sunita Holkar; Deovrat Begde; Nandita Nashikkar; Tukaram Kadam; Avinash Upadhyay
Journal:  Springerplus       Date:  2013-03-09

5.  CytA, a reductase in the cytorhodin biosynthesis pathway, inactivates anthracycline drugs in Streptomyces.

Authors:  Chun Gui; Jiang Chen; Qing Xie; Xuhua Mo; Shanwen Zhang; Hua Zhang; Junying Ma; Qinglian Li; Yu-Cheng Gu; Jianhua Ju
Journal:  Commun Biol       Date:  2019-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.